Plasma calprotectin as an indicator of need of transfer to Intensive care in patients with suspected Sepsis at the emergency department

Ayham Maatouk

doi:10.53730/ijhs.v7nS1.14525

Authors

Ayham Maatouk
ayhammaatouk@yahoo.com

Keywords:

Plasma calprotectin, Intensive care, suspected Sepsis

Abstract

Sepsis frequently necessitates hospitalization & admission to high-dependency units & intensive care units. Sepsis is responsible for twenty percent of all fatalities worldwide, according to the most current Global Burden of Disease Study. Sepsis is reported to have a mortality rate of between twelve percent and twenty percent in western nations. "Neonate" & "adult" categories, nevertheless, both demonstrated high diagnostic effectiveness, indicating that demographic context had not been the primary reason for variability. Heterogeneity can be the result of the sepsis definition detection & treatment of sepsis have improved over the past few decades as a result of extensive study, & criteria have evolved as a result. To improve it, sepsis-3 had been created in 2016 with a stronger emphasis on identifying organ dysfunction in the context of infection understanding of the syndrome is constantly expanding. More investigation into this interesting diagnostic sign utilizing a revised definition is needed, hence.

Downloads

Download data is not yet available.

References

Parke, A. E, Unge, C, Yu, D, Sunden-Cullberg, J, Stralin, K. (2021). Plasma-Calprotectin as an Indicator for Immediate Need of Intensive Care Treatment in Suspected Sepsis.

Larsson, A, Tydén, J, Johansson, J, Lipcsey, M, Bergquist, M, Kultima, K, et al. (2020). Calprotectin is superior to procalcitonin as a sepsis marker and predictor of 30-day mortality in intensive care patients. Scandinavian Journal of Clinical and Laboratory Investigation, 80(2), 156-161.

Barichello, T, Generoso, J. S, Singer, M, Dal-Pizzol, F. (2022). Biomarkers for sepsis: more than just fever and leukocytosis—a narrative review. Critical Care, 26(1), 14.

Gauchel, N, Rieder, M, Krauel, K, Goller, I, Jeserich, M, Salzer, U, et al. (2022). Complement system component dysregulation is a distinctive feature of COVID-19 disease: A prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease. Journal of Thrombosis and Thrombolysis, 1-10.

García de Guadiana-Romualdo, L, Rodríguez Rojas, C, Morell-García, D, Andaluz-Ojeda, D, Rodríguez Mulero, M. D, Rodríguez-Borja, E, et al. (2022). Circulating levels of calprotectin, a signature of neutrophil activation in prediction of severe respiratory failure in COVID-19 patients: a multicenter, prospective study (CalCov study). Inflammation Research, 1-11.

Chapuis, N, Ibrahimi, N, Belmondo, T, Goulvestre, C, Berger, A. E, Mariaggi, A. A, et al. (2022). Dynamics of circulating calprotectin accurately predict the outcome of moderate COVID-19 patients. EBioMedicine, 80, 104077.

Wollmer, M, Wändell, P, Rosenqvist, M, Larsson, A, Melander, O, Wessman, T, et al. (2021). Plasma calprotectin in the emergency department: a potential clinical biomarker for patients with infectious diseases. Scandinavian Journal of Clinical and Laboratory Investigation, 81(7), 593-597.

Christensen, E. E, Binde, C, Leegaard, M, Tonby, K, Dyrhol-Riise, A. M, Kvale, D, et al. (2022). Diagnostic accuracy and added value of infection biomarkers in patients with possible sepsis in the Emergency Department. Shock: Injury, Inflammation, and Sepsis: Laboratory and Clinical Approaches, 58(4), 251-259.

Lipcsey, M, Hanslin, K, Stålberg, J, Smekal, D, Larsson, A. (2019). The time course of calprotectin liberation from human neutrophil granulocytes after Escherichia coli and endotoxin challenge. Innate immunity, 25(6), 369-373.

Havelka, A, Sejersen, K, Venge, P, Pauksens, K, Larsson, A. (2020). Calprotectin, a new biomarker for diagnosis of acute respiratory infections. Scientific reports, 10(1), 4208.

Cherubini, F, Cristiano, A, Valentini, A, Bernardini, S, Nuccetelli, M. (2021). Circulating calprotectin as a supporting inflammatory marker in discriminating SARS-CoV-2 infection: an observational study. Inflammation Research, 70(6), 687-694.

Nevejan, L, Strypens, T, Van Nieuwenhove, M, Boel, A, Cattoir, L, Meeus, P, et al. (2022). Prognostic value of circulating calprotectin levels on the clinical course of COVID-19 differs between serum, heparin, EDTA and citrate sample types. Clinica Chimica Acta, 525, 54-61.

Van der Slikke, E. C, Boekhoud, L, Bourgonje, A. R, Olgers, T. J, Ter Maaten, J. C, Henning, R. H, et al. (2022). Plasma free thiol levels during early sepsis predict future renal function decline. Antioxidants, 11(5), 800.

Reyes, M, Filbin, M. R, Bhattacharyya, R. P, Sonny, A, Mehta, A, Billman, K, et al. (2021). Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro. Science translational medicine, 13(598), eabe9599.